Outcome of Early Initiation of High-flow Nasal Oxygen Therapy among Pneumonia Patients Presenting with Acute Hypoxemic Respiratory Failure.

IF 1.5 Q3 CRITICAL CARE MEDICINE Indian Journal of Critical Care Medicine Pub Date : 2024-08-01 Epub Date: 2024-07-31 DOI:10.5005/jp-journals-10071-24769
Doaa M Magdy
{"title":"Outcome of Early Initiation of High-flow Nasal Oxygen Therapy among Pneumonia Patients Presenting with Acute Hypoxemic Respiratory Failure.","authors":"Doaa M Magdy","doi":"10.5005/jp-journals-10071-24769","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>High-flow nasal oxygen (HFNO) therapy is an upcoming and beneficial modality for patients with acute hypoxemic respiratory failure (AHRF).</p><p><strong>Objectives: </strong>To evaluate whether early use of HFNO in pneumonia patients with AHRF can reduce the need for invasive ventilation.</p><p><strong>Patients and methods: </strong>In this prospective, randomized controlled trial, 160 patients who fulfilled the criteria were included. The patient's characteristics, sequential organ failure assessment score, and simplified acute physiology score were recorded. Respiratory rate (RR), and oxygenation parameters (PaO<sub>2</sub>/FiO<sub>2</sub>), and RR-oxygenation index at selected time intervals were collected and analyzed. The primary outcome was the number of patients who needed intubation. Secondary outcomes included length of intensive care unit (ICU) and hospital stay and mortality at day 28.</p><p><strong>Results: </strong>The rate of intubation was not statistically significant between the two groups 15 vs 18.7%; difference 3.7% [(95% confidence interval (CI): 2.5-5.7%]. In 48-hour time periods, the mean PaO<sub>2</sub>/FiO<sub>2</sub> ratio was significantly increased in the HFNO group compared with the non-invasive ventilation (NIV) group. The RRs and heart rate (HR) showed a significant decrease in the HFNO group.The length of ICU and hospital stays was not different between both groups. No significant differences were found in mortality rates between the HFNO and NIV groups 9 (11.2%) and 10 (12.5%), with 1.3% (95% CI: 0.7-3.8%) (<i>p</i> = 0.21). Multivariate analysis demonstrated that low baseline PaO<sub>2</sub>/FiO<sub>2</sub>, Respiratory rate-oxygenation index (ROX index) ≤ 5.4 measured at 12 hour and high severity scores were independent risk factors for intubation.</p><p><strong>Conclusion: </strong>Treatment with HFNO did not reduce the need for intubation among patients with pneumonia-induced AHRF, despite the improved PaO<sub>2</sub>/FiO<sub>2</sub> observed with HFNO compared with NIV.</p><p><strong>Clinical trial no: </strong>NCT05809089.</p><p><strong>How to cite this article: </strong>Magdy DM. Outcome of Early Initiation of High-flow Nasal Oxygen Therapy among Pneumonia Patients Presenting with Acute Hypoxemic Respiratory Failure. Indian J Crit Care Med 2024;28(8):753-759.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 8","pages":"753-759"},"PeriodicalIF":1.5000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372677/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10071-24769","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: High-flow nasal oxygen (HFNO) therapy is an upcoming and beneficial modality for patients with acute hypoxemic respiratory failure (AHRF).

Objectives: To evaluate whether early use of HFNO in pneumonia patients with AHRF can reduce the need for invasive ventilation.

Patients and methods: In this prospective, randomized controlled trial, 160 patients who fulfilled the criteria were included. The patient's characteristics, sequential organ failure assessment score, and simplified acute physiology score were recorded. Respiratory rate (RR), and oxygenation parameters (PaO2/FiO2), and RR-oxygenation index at selected time intervals were collected and analyzed. The primary outcome was the number of patients who needed intubation. Secondary outcomes included length of intensive care unit (ICU) and hospital stay and mortality at day 28.

Results: The rate of intubation was not statistically significant between the two groups 15 vs 18.7%; difference 3.7% [(95% confidence interval (CI): 2.5-5.7%]. In 48-hour time periods, the mean PaO2/FiO2 ratio was significantly increased in the HFNO group compared with the non-invasive ventilation (NIV) group. The RRs and heart rate (HR) showed a significant decrease in the HFNO group.The length of ICU and hospital stays was not different between both groups. No significant differences were found in mortality rates between the HFNO and NIV groups 9 (11.2%) and 10 (12.5%), with 1.3% (95% CI: 0.7-3.8%) (p = 0.21). Multivariate analysis demonstrated that low baseline PaO2/FiO2, Respiratory rate-oxygenation index (ROX index) ≤ 5.4 measured at 12 hour and high severity scores were independent risk factors for intubation.

Conclusion: Treatment with HFNO did not reduce the need for intubation among patients with pneumonia-induced AHRF, despite the improved PaO2/FiO2 observed with HFNO compared with NIV.

Clinical trial no: NCT05809089.

How to cite this article: Magdy DM. Outcome of Early Initiation of High-flow Nasal Oxygen Therapy among Pneumonia Patients Presenting with Acute Hypoxemic Respiratory Failure. Indian J Crit Care Med 2024;28(8):753-759.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
出现急性低氧血症呼吸衰竭的肺炎患者早期开始高流量鼻氧疗法的效果。
背景:高流量鼻氧(HFNO)疗法是一种即将对急性低氧血症呼吸衰竭(AHRF)患者有益的治疗方式:患者与方法:在这项前瞻性随机对照研究中,肺炎患者和呼吸衰竭患者均接受了高流量鼻氧治疗:在这项前瞻性随机对照试验中,共纳入了 160 名符合标准的患者。记录了患者的特征、器官功能衰竭顺序评估评分和简化急性生理学评分。收集并分析选定时间间隔内的呼吸频率(RR)、氧合参数(PaO2/FiO2)和 RR 氧合指数。主要结果是需要插管的患者人数。次要结果包括重症监护室(ICU)和住院时间以及第28天的死亡率:两组患者的插管率无统计学意义,分别为 15% vs 18.7%;差异为 3.7%[(95% 置信区间(CI):2.5%-5.7%]。与无创通气(NIV)组相比,高频NO组在48小时内的平均PaO2/FiO2比值显著增加。两组的重症监护室和住院时间没有差异。高频硝化组和 NIV 组的死亡率无明显差异,分别为 9(11.2%)和 10(12.5%),1.3%(95% CI:0.7-3.8%)(P = 0.21)。多变量分析表明,基线 PaO2/FiO2 低、12 小时时呼吸速率-氧合指数(ROX 指数)≤ 5.4 和严重程度评分高是插管的独立风险因素:临床试验编号:NCT05809089.文章引用方式:Magdy DM:Magdy DM.出现急性低氧血症呼吸衰竭的肺炎患者早期开始高流量鼻氧治疗的效果。Indian J Crit Care Med 2024;28(8):753-759.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.50
自引率
10.00%
发文量
299
期刊介绍: Indian Journal of Critical Care Medicine (ISSN 0972-5229) is specialty periodical published under the auspices of Indian Society of Critical Care Medicine. Journal encourages research, education and dissemination of knowledge in the fields of critical and emergency medicine.
期刊最新文献
Care Beyond Cure: Humanizing the Intensive Care Unit Journey. Clinical Characteristics of Obstetric Patients Admitted in ICU During COVID-19 Pandemic and its Comparison with Pre-COVID Period: A Retrospective Analysis from North India. Communication, Shared Decision-making and Goals of Care in the ICU through Electronic Health Records: A Scoping Review. Comparison of Nebulized Glycopyrronium with a Combination of Salbutamol and Ipratropium on Ventilatory Parameters in Critically Ill Mechanically Ventilated Patients of Chronic Obstructive Pulmonary Disease: An Observational Study. Comparison of Trends of Procalcitonin and Neutrophil to Lymphocyte Ratio in Patients of Sepsis in Intensive Care Unit.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1